Filing Details
- Accession Number:
- 0001181431-12-029232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-10 20:17:29
- Reporting Period:
- 2012-05-10
- Filing Date:
- 2012-05-10
- Accepted Time:
- 2012-05-10 19:17:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275857 | A James Mcnulty | C/O Biodelivery Sciences Intl, Inc. 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-08 | 6,093 | $2.01 | 49,252 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-05-08 | 15,603 | $2.05 | 64,855 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-08 | 21,696 | $4.00 | 43,159 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options | Disposition | 2012-05-08 | 6,093 | $0.00 | 6,093 | $2.01 |
Common Stock | Options | Disposition | 2012-05-08 | 15,603 | $0.00 | 15,603 | $2.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,092 | 2009-07-24 | 2018-07-24 | No | 4 | M | Direct |
0 | 2007-07-27 | 2016-07-27 | No | 4 | M | Direct |
Footnotes
- The sale of the shares of common stock was undertaken pursuant to a pre-arranged 10b5-1 plan previously implemented by the reporting person.